Erratum: Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals (Journal of Clinical Investigation (2008) 118, 10, (3478-3490) doi:10.1172/JCI32460);Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals

Journal of Clinical Investigation

Volumn 118, Issue 10, 2008, Pages 3478-3490

  Lee, Laurel Yong Hwa ^a   Ha, Do Lien Anh ^b   Simmons, Cameron ^b   De Jong, Menno D ^b   Chau, Nguyen Van Vinh ^b   Schumacher, Reto ^a   Yan, Chun Peng ^a   McMichael, Andrew J ^a,d   Farrar, Jeremy J ^b   Smith, Geoffrey L ^c   Townsend, Alain R M ^a   Askonas, Brigitte A ^a   Rowland Jones, Sarah ^a   Dong, Tao ^a,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN; NUCLEOPROTEIN; PROTEOME;

ARTICLE; AVIAN INFLUENZA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; EX VIVO STUDY; HUMAN; INFLUENZA VIRUS A; INFLUENZA VIRUS A H5N1; MEMORY T LYMPHOCYTE; MOLECULAR RECOGNITION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UNITED KINGDOM; UNITED STATES; VACCINIA VIRUS; VIET NAM; VIRUS STRAIN;

EID: 55849125109     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI66865     Document Type: Erratum

References (75)

1. WHO. 2008. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. http://www.who.int/csr/disease/avian_influenza/ country/cases_table_2008_06_19/en/ index.html.
2. Abdel-Ghafar, A.N., et al. 2008. Update on avian influenza A (H5N1) virus infection in humans. N. Engl. J. Med. 358:261-273.
3. Horimoto, T., et al. 2004. Antigenic differences between H5N1 human influenza viruses isolated in 1997 and 2003. J. Vet. Med. Sci. 66:303-305.
4. Li, K.S., et al. 2004. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature. 430:209-213.
5. WHO. 2007. Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines. http://www.who.int/csr/disease/avian_influenza/guidelines/ recommendationvaccine.pdf.
6. Bresson, J.L., et al. 2006. Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial. Lancet. 367:1657-1664.
7. Lin, J., et al. 2006. Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial. Lancet. 368:991-997.
8. Treanor, J.J., Campbell, J.D., Zangwill, K.M., Rowe, T., and Wolff, M. 2006. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N. Engl. J. Med. 354:1343-1351.
9. Leroux-Roels, I., et al. 2007. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet. 370:580-589.
10. Leroux-Roels, I., et al. 2008. Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine. PLoS ONE. 3:e1665.
11. Thomas, P.G., Keating, R., Hulse-Post, D.J., and Doherty, P.C. 2006. Cell-mediated protection in influenza infection. Emerg. Infect. Dis. 12:48-54.
12. Rimmelzwaan, G.F., Fouchier, R.A.M., and Osterhaus, A.D.M.E. 2007. Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development. Curr. Opin. Biotechnol. 18:529-536.
13. Yap, K.L., Ada, G.L., and McKenzie, I.F. 1978. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature. 273:238-239.
14. Lin, Y.L., and Askonas, B.A. 1981. Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions. J. Exp. Med. 154:225-234.
15. McMichael, A.J., Gotch, F.M., Noble, G.R., and Beare, P.A. 1983. Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 309:13-17.
16. Bennink, J.R., Yewdell, J.W., and Gerhard, W. 1982. A viral polymerase involved in recognition of influenza virus-infected cells by a cytotoxic T-cell clone. Nature. 296:75-76.
17. Townsend, A.R., and Skehel, J.J. 1982. Influenza A specific cytotoxic T-cell clones that do not recognize viral glycoproteins. Nature. 300:655-657.
18. Townsend, A.R., and Skehel, J.J. 1984. The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells. J. Exp. Med. 160:552-563.
19. Yewdell, J.W., Bennink, J.R., Smith, G.L., and Moss, B. 1985. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 82:1785-1789.
20. McMichael, A.J., Michie, C.A., Gotch, F.M., Smith, G.L., and Moss, B. 1986. Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. J. Gen. Virol. 67:719-726.
21. Gotch, F., McMichael, A., Smith, G., and Moss, B. 1987. Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. J. Exp. Med. 165:408-416.
22. Taylor, P.M., and Askonas, B.A. 1986. Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. Immunology. 58:417-420.
23. + T-cell repertoire of responses to influenza A virus hemagglutinin after recent natural infection. J. Virol. 69:7497-7506.
24. Jameson, J., Cruz, J., and Ennis, F.A. 1998. Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J. Virol. 72:8682-8689.
25. McMichael, A.J., and Askonas, B.A. 1978. Influenza virus-specific cytotoxic T cells in man; induction and properties of the cytotoxic cell. Eur. J. Immunol. 8:705-711.
26. Biddison, W.E., Shaw, S., and Nelson, D.L. 1979. Virus specificity of human influenza virus-immune cytotoxic T cells. J. Immunol. 122:660-664.
27. Gianfrani, C., Oseroff, C., Sidney, J., Chesnut, R.W., and Sette, A. 2000. Human memory CTL response specific for influenza A virus is broad and multispecific. Hum. Immunol. 61:438-452.
28. + T lymphocyte memory to influenza A viruses of swine and avian species. J. Immunol. 162:7578-7583.
29. Kreijtz, J., et al. 2008. Cross-recognition of avian H5N1 influenza virus by human cytotoxic T lymphocyte populations directed to human influenza A virus. J. Virol. 82:5161-5166.
30. Bui, H.H., Peters, B., Assarsson, E., Mbawuike, I., and Sette, A. 2007. Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc. Natl. Acad. Sci. U. S. A. 104:246-251.
31. + memory T Cell responses directed against common respiratory pathogens in peripheral blood and lung. J. Infect. Dis. 195:1718-1725.
32. Tang, J., et al. 2004. Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele. Gene Ther. 11:1408-1415.
33. Mayer, S., Laumer, M., Mackensen, A., Andreesen, R., and Krause, S.W. 2002. Analysis of the immune response against tetanus toxoid: enumeration of specific T helper cells by the Elispot assay. Immunobiology. 205:282-289.
34. Papagno, L., et al. 2002. Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors. Clin. Exp. Immunol. 130:509-517.
35. Townsend, A., et al. 1988. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J. Exp. Med. 168:1211-1224.
36. + T lymphocytes. J. Immunol. 172:2453-2460.
37. Gotch, F., Rothbard, J., Howland, K., Townsend, A., and McMichael, A. 1987. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature. 326:881-882.
38. Ulmer, J.B., et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1745-1749.
39. + memory T cells. J. Exp. Med. 186:859-865.
40. Morris, A.G., Lin, Y.L., and Askonas, B.A. 1982. Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell. Nature. 295:150-152.
41. de Jong, M.D., et al. 2005. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N. Engl. J. Med. 352:686-691.
42. + T cells. Blood. 107:4781-4789.
43. Darrah, P.A., et al. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13:843-850.
44. Duvall, M.G., et al. 2008. Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur. J. Immunol. 38:350-363.
45. Goulding, J., et al. 2007. Respiratory infections: do we ever recover? Proc. Am. Thorac. Soc. 4:618-625.
46. Boon, A.C., et al. 2004. Preferential HLA usage in the influenza virus-specific CTL response. J. Immunol. 172:4435-4443.
47. Mbawuike, I.N., Lange, A.R., and Couch, R.B. 1993. Diminished influenza A virus-specific MHC class I-restricted cytotoxic T lymphocyte activity among elderly persons. Viral Immunol. 6:55-64.
48. + T cell immunodominance hierarchy determined by antigen dose and precursor frequencies. Proc. Natl. Acad. Sci. U. S. A. 103:994-999.
49. Selin, L.K., et al. 1999. Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity. 11:733-742.
50. Epstein, S. 2006. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J. Infect. Dis. 193:49-53.
51. McMichael, A.J., Gotch, F.M., Dongworth, D.W., Clark, A., and Potter, C.W. 1983. Declining T-cell immunity to influenza, 1977-82. Lancet. 2:762-764.
52. Sidney, J., Grey, H.M., Kubo, R.T., and Sette, A. 1996. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol. Today. 17:261-266.
53. Sidney, J., Peters, B., Frahm, N., Brander, C., and Sette, A. 2008. HLA class I supertypes: a revised and updated classification. BMC Immunol. 9:1.
54. Bui, H.H., et al. 2006. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics. 7:153.
55. + T cells directed against H5N1 influenza virus. J. Immunol. 180:1758-1768.
56. Wang, M., et al. 2007. CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening. Vaccine. 25:2823-2831.
57. Peters, B., et al. 2005. The immune epitope database and analysis resource: from vision to blueprint. PLoS Biol. 3:e91.
58. Nichol, K.L., et al. 1999. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA. 282:137-144.
59. Belshe, R.B., et al. 2000. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J. Pediatr. 136:168-175.
60. Suguitan, A.L., Jr., et al. 2006. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med. 3:e360.
61. Roederer, M., and Koup, R.A. 2003. Optimized determination of T cell epitope responses. J. Immunol. Methods. 274:221-228.
62. + effector and memory T cell generation. Nat. Immunol. 4:835-842.
63. + T cells during an acute virus infection. Immunity. 8:167-175.
64. Blattman, J.N., et al. 2002. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J. Exp. Med. 195:657-664.
65. Rowland-Jones, S.L., et al. 1998. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J. Clin. Invest. 102:1758-1765.
66. Dong, T., et al. 1996. An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide. Eur. J. Immunol. 26:335-339.
67. Chakrabarti, S., Brechling, K., and Moss, B. 1985. Vaccinia virus expression vector: coexpression of betagalactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403-3409.
68. Smith, G.L., Murphy, B.R., and Moss, B. 1983. Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proc. Natl. Acad. Sci. U. S. A. 80:7155-7159.
69. Mackett, M., Smith, G.L., and Moss, B. 1984. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Virol. 49:857-864.
70. Linnemann, T., Jung, G., and Walden, P. 2000. Detection and quantification of CD4(+) T cells with specificity for a new major histocompatibility complex class II-restricted influenza A virus matrix protein epitope in peripheral blood of influenza patients. J. Virol. 74:8740-8743.
71. McMichael, A.J., Gotch, F., Cullen, P., Askonas, B., and Webster, R.G. 1981. The human cytotoxic T cell response to influenza A vaccination. Clin. Exp. Immunol. 43:276-284.
72. Adler, S., Reay, P., Roy, P., and Klenk, H.D. 1998. Induction of T cell response by bluetongue virus core-like particles expressing a T cell epitope of the M1 protein of influenza A virus. Med. Microbiol. Immunol. 187:91-96.
73. DiBrino, M., et al. 1995. Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population. Biochemistry. 34:10130-10138.
74. Brett, S.J., et al. 1991. Human T cell recognition of influenza A nucleoprotein. Specificity and genetic restriction of immunodominant T helper cell epitopes. J. Immunol. 147:984-991.
75. DiBrino, M., et al. 1993. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. J. Immunol. 151:5930-5935.